The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202547 · Cited by 497
Tyrosine kinase receptor indistinguishable from the c-met protein
Giordano, S., Ponzetto, C., Renzo, M. F. D., Cooper, C. S., & Comoglio, P. M. (1989) · Nature · doi:10.1038/339155a0 · Cited by 490
Self-citationDifferential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases
Marais, R., Light, Y., Paterson, H. F., Mason, C. S., & Marshall, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4378 · Cited by 456
Activating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Uncoupling of Grb2 from the Met Receptor In Vivo Reveals Complex Roles in Muscle Development
Maina, F., Casagranda, F., Audero, E., Simeone, A., Comoglio, P. M., Klein, R., & Ponzetto, C. (1996) · Cell · doi:10.1016/s0092-8674(00)81372-0 · Cited by 311
Self-citationThe mutationally activated Met receptor mediates motility and metastasis
Jeffers, M., Fiscella, M., Webb, C. P., Anver, M., Koochekpour, S., & Vande Woude, G. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14417 · Cited by 224
Expression of c-met is a strong independent prognostic factor in breast carcinoma
Ghoussoub, R. A. D., Dillon, D. A., D'Aquila, T., Rimm, E. B., Fearon, E. R., & Rimm, D. L. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7 · Cited by 217
cAMP stimulates protein kinase B in a Wortmannin‐insensitive manner
Sable, C. L., Filippa, N., Hemmings, B., & Van Obberghen, E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00518-8 · Cited by 166
Specific Uncoupling of GRB2 from the Met Receptor
Ponzetto, C., Zhen, Z., Audero, E., Maina, F., Bardelli, A., Basile, M. L., Giordano, S., Narsimhan, R. P., & Comoglio, P. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14119 · Cited by 152
Self-citationFischer, J., Palmedo, G., von Knobloch, R., Bugert, P., Prayer-Galetti, T., Pagano, F. C., & Kovács, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201983 · Cited by 141
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
Michieli, P., Basilico, C., Pennacchietti, S., Maffé, A., Tamagnone, L., Giordano, S., Bardelli, A., & Comoglio, P. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202899 · Cited by 140
Self-citationMédico, E., Mongiovì, A. M., Huff, J. L., Jelinek, M. A., Follenzi, A., Gaudino, G., Parsons, J. T., & Comoglio, P. M. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.4.495 · Cited by 135
Self-citationRole of morphogenetic factors in metastasis of mammary carcinoma cells
Meiners, S., Brinkmann, V., Naundorf, H., & Birchmeier, W. (1998) · Oncogene · doi:10.1038/sj.onc.1201486 · Cited by 121
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
Liang, T. J., Reid, A. E., Xavier, R. J., Cardiff, R. D., & Wang, T. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118744 · Cited by 115
Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver
Masumoto, A., & Yamamoto, N. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90489-t · Cited by 110
Bardelli, A., Longati, P., Gramaglia, D., Basilico, C., Tamagnone, L., Giordano, S., Ballinari, D., Michieli, P., & Comoglio, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14379 · Cited by 106
Self-citationA point mutation in the MET oncogene abrogates metastasis without affecting transformation
Giordano, S., Bardelli, A., Zhen, Z., Ménard, S., Ponzetto, C., & Comoglio, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13868 · Cited by 92
Self-citationOverexpression of scatter factor and its receptor (c‐met) in oral squamous cell carcinoma
Marshall, D. D., & Rornberg, L. J. (1998) · The Laryngoscope · doi:10.1097/00005537-199809000-00031 · Cited by 56
Galeazzi, E., Olivero, M., Gervasio, C. F., Stefani, A. D., Valente, G., Comoglio, P. M., Renzo, M. F. D., & Cortesina, G. (1997) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf02439745 · Cited by 50
Self-citationExpression of c-Met in laryngeal carcinoma
Sawatsubashi, M., Sasatomi, E., Mizokami, H., Tokunaga, O., & Shin, T. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050174 · Cited by 46
“Invasive-growth” signaling by the Met/HGF receptor
Bardelli, A., Pugliese, L., & Comoglio, P. M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00026-7 · Cited by 45
Self-citation
Cited by
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311
Self-citationDrug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
Self-citationZou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Metadata
- Authors
- Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M.
- Venue
- Oncogene
- Published
- 2000-03-16
- Volume
- 19
- Issue
- 12
- Pages
- 1547-1555
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2005092992
- Cited by
- 332
- References
- 27
- FWCI
- 13.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.